|
US3943124A
(en)
*
|
1970-12-17 |
1976-03-09 |
Gordon Hanley Phillipps |
Chemical compounds
|
|
US3989686A
(en)
*
|
1972-06-15 |
1976-11-02 |
Glaxo Laboratories Limited |
Anaesthetic steroids of the androstane series and process for preparing same
|
|
GB1514476A
(en)
*
|
1974-08-30 |
1978-06-14 |
Glaxo Lab Ltd |
Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
|
|
US4093721A
(en)
*
|
1974-08-30 |
1978-06-06 |
Glaxo Laboratories Limited |
Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
|
|
DK118776A
(da)
*
|
1975-03-21 |
1976-09-22 |
Schering Ag |
Pregnansyrederivater
|
|
CH628355A5
(de)
*
|
1976-02-24 |
1982-02-26 |
Ciba Geigy Ag |
Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
|
|
IT1114534B
(it)
*
|
1978-02-08 |
1986-01-27 |
Glaxo Group Ltd |
Steroide anti-infiammatorio della serie dell'androstano composizioni che lo contengono e procedimento per produrlo
|
|
US4187301A
(en)
*
|
1978-04-05 |
1980-02-05 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
|
|
US4188385A
(en)
*
|
1978-04-05 |
1980-02-12 |
Syntex (U.S.A.) Inc. |
Thioetianic acid derivatives
|
|
US4252729A
(en)
*
|
1978-05-12 |
1981-02-24 |
Hoffmann-La Roche Inc. |
Steroids and process for their manufacture
|
|
NL191792C
(nl)
*
|
1980-02-15 |
1996-08-02 |
Glaxo Group Ltd |
Esters van een androstaan-17beta-carbothiozuur, werkwijze ter bereiding van deze esters, en farmaceutische preparaten, die deze esters bevatten.
|
|
SE449106B
(sv)
*
|
1980-07-10 |
1987-04-06 |
Otsuka Pharma Co Ltd |
Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
|
|
US4710495A
(en)
*
|
1980-07-10 |
1987-12-01 |
Otsuka Pharmaceutical Co., Ltd. |
Soft steroids having anti-inflammatory activity
|
|
US4996335A
(en)
*
|
1980-07-10 |
1991-02-26 |
Nicholas S. Bodor |
Soft steroids having anti-inflammatory activity
|
|
CH649923A5
(de)
*
|
1980-10-06 |
1985-06-28 |
Glaxo Group Ltd |
Topisch verabreichbare pharmazeutische zusammensetzungen, enthaltend anti-inflammatorische steroide.
|
|
SE8306370D0
(sv)
*
|
1983-11-18 |
1983-11-18 |
Draco Ab |
Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
|
|
SE8501693D0
(sv)
*
|
1985-04-04 |
1985-04-04 |
Draco Ab |
Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
|
|
IL78144A0
(en)
*
|
1985-04-04 |
1986-07-31 |
Draco Ab |
Novel androstane-17beta-carboxylic acid esters
|
|
US4686214A
(en)
*
|
1985-10-30 |
1987-08-11 |
Alcon Laboratories, Inc. |
Anti-inflammatory compounds for ophthalmic use
|
|
ATE90355T1
(de)
*
|
1987-10-13 |
1993-06-15 |
Nicholas S Bodor |
Weiche steroide mit anti-entzuendungswirkung.
|
|
US5981517A
(en)
*
|
1996-05-09 |
1999-11-09 |
Soft Drugs, Inc. |
Androstene derivatives
|
|
GB0015876D0
(en)
*
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
|
AR032471A1
(es)
*
|
2000-08-05 |
2003-11-12 |
Glaxo Group Ltd |
Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter
|
|
US6858596B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
|
US6777399B2
(en)
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6777400B2
(en)
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6858593B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
|
US6787532B2
(en)
|
2000-08-05 |
2004-09-07 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivatives
|
|
US6750210B2
(en)
|
2000-08-05 |
2004-06-15 |
Smithkline Beecham Corporation |
Formulation containing novel anti-inflammatory androstane derivative
|
|
GB0019172D0
(en)
*
|
2000-08-05 |
2000-09-27 |
Glaxo Group Ltd |
Novel compounds
|
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
|
CA2445839A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
|
GB0125259D0
(en)
*
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
|
AU2003202044A1
(en)
*
|
2002-01-15 |
2003-09-09 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
|
WO2003062259A2
(en)
*
|
2002-01-21 |
2003-07-31 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
|
GB0202216D0
(en)
*
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
|
US20050175545A1
(en)
*
|
2002-02-04 |
2005-08-11 |
Keith Biggadike |
Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
|
|
GB0202635D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Wellcome Mfg Pte Ltd |
Formulation containing novel anti-inflammatory androstane derivative
|
|
GB2389530B
(en)
|
2002-06-14 |
2007-01-10 |
Cipla Ltd |
Pharmaceutical compositions
|
|
GB0225287D0
(en)
*
|
2002-10-30 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
|
DE602004008083T2
(de)
|
2003-06-19 |
2008-04-24 |
Nicholas S. Gainsville Bodor |
Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden
|
|
GB0316290D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
|
JP5281291B2
(ja)
*
|
2005-01-10 |
2013-09-04 |
グラクソ グループ リミテッド |
新規化合物
|
|
US20090124588A1
(en)
*
|
2005-01-10 |
2009-05-14 |
Glaxo Group Limited |
Androstane 17-Alpha-Carbonate for Use in the Treatment of Inflammatory and Allergic Conditions
|
|
GB0507165D0
(en)
*
|
2005-04-08 |
2005-05-18 |
Glaxo Group Ltd |
Novel crystalline pharmaceutical product
|
|
US20070245924A1
(en)
*
|
2006-04-20 |
2007-10-25 |
Hofmann Michael A |
Reduced abrasion of titanium dioxide pigments produced from the chloride process
|
|
GB0615108D0
(en)
*
|
2006-07-28 |
2006-09-06 |
Glaxo Group Ltd |
Novel formulations
|
|
WO2012056201A2
(en)
|
2010-10-27 |
2012-05-03 |
Hovione Inter Limited |
Electrophilic reagents for monohalomethylation,their preparation and their uses
|